Table S2.
Quantitative PET data of tracer biodistribution after CD105 or EGFR blocking in U87MG tumor-bearing mice
| Hours p.i. of the tracer | |||||
| Blocking group | Tissue | 3 h | 15 h | 24 h | 36 h |
| 64Cu-Bs-F(ab)2 + CD105 blocking, n = 4 | U87MG | 11.5 ± 1.2 | 13.7 ± 2.6 | 13.7 ± 2.5 | 12.0 ± 1.8 |
| Blood | 15.5 ± 9.6 | 9.6 ± 1.2 | 8.6 ± 1.4 | 6.3 ± 1.1 | |
| Liver | 17.2 ± 1.4 | 12.0 ± 2.2 | 11.7 ± 2.1 | 8.8 ± 1.4 | |
| Kidney | 9.5 ± 1.4 | 7.4 ± 0.9 | 6.9 ± 1.0 | 5.3 ± 0.5 | |
| Muscle | 1.3 ± 0.2 | 2.0 ± 1.0 | 1.5 ± 0.3 | 1.3 ± 0.1 | |
| 64Cu-Bs-F(ab)2 + EGFR blocking, n = 4 | U87MG | 14.4 ± 3.9 | 20.3 ± 2.4 | 20.3 ± 3.1 | 19.3 ± 1.9 |
| Blood | 8.1 ± 1.5 | 5.6 ± 0.3 | 4.1 ± 0.4 | 3.4 ± 0.2 | |
| Liver | 10.2 ± 2.8 | 7.4 ± 0.5 | 7.0 ± 0.5 | 4.9 ± 0.4 | |
| Kidney | 5.7 ± 0.8 | 5.2 ± 0.4 | 4.6 ± 0.4 | 2.5 ± 1.1 | |
| Muscle | 1.2 ± 0.2 | 1.2 ± 0.1 | 1.3 ± 0.2 | 0.9 ± 0.3 | |
Values are reported as %ID/g (mean ± SD).